An ingredient supplier recently reported that unpublished trials suggest D-ribose improves marathon performance, but veteran athletes should wait for peer review.
On October 9, 2026, Nutrition Insight reported that ingredient supplier Bioenergy Life Science (BLS) summarized findings from two unpublished Beijing Sport University trials. These studies involved amateur marathon runners and tested the effects of D-ribose supplementation on endurance and recovery. The findings currently remain unpublished in any peer-reviewed academic journal. Instead of independent validation, the public account relies entirely on the ingredient supplier to summarize the outcomes.
This dynamic creates a complicated situation for endurance athletes looking for reliable nutrition guidance. We are left with intriguing supplier claims but lack the rigorous scientific data needed to verify them. Reading beyond the headlines is critical when evaluating any new sports nutrition trend.
The central claim from the supplier is that D-ribose helps runners finish faster and recover better. According to BLS general manager Michael Crabtree, D-ribose research has identified a role for the compound in restoring depleted cellular ATP pools after exercise. ATP serves as the primary energy currency for cellular function, making its restoration vital for athletic recovery. Crabtree called the ingredient "safe, and effective" in his public statement.
The supplier summary suggests that the supplement directly addresses the heavy physical toll caused by long-distance endurance events. BLS reported that supplemented groups showed reductions in multiple biomarkers associated with exercise-related cardiac and muscle stress. This implies that the body endures less overall internal strain during a grueling effort. Furthermore, the supplier reported notable improvements in post-exercise heart-rate recovery among some test subjects.
According to the supplier account, a specific split-dose protocol improved three-minute post-exercise heart-rate recovery significantly. They reported a 9.4 percent improvement for men and a 6.5 percent improvement for women using this split dose. The summary also claimed that a single dose shortened overall race completion times by 5 percent in men. Women reportedly saw a 6 percent reduction in completion time with that same single dose.
Finally, the split dose was reported to reduce completion times for men by 5.4 percent. These numbers sound impressive on the surface, but they require deeper context to evaluate properly.
The reported research actually consists of two distinct trials with entirely different testing protocols. The first trial specifically targeted middle-aged and older endurance athletes. Researchers enrolled 40 male amateur marathon runners aged 45 to 65 for this study. This older-athlete trial was described as a randomized, double-blind, and multi-dose experiment.
Participants completed eight weeks of daily supplementation before running a half-marathon simulation. During those eight weeks, runners took daily doses of 6, 12, or 18 grams of D-ribose.
The second trial focused on a much smaller and younger demographic of runners. This group enrolled 20 young amateur runners, balanced evenly with 10 men and 10 women. The supplier described this second study as a randomized, double-blind crossover trial that used placebo controls. Instead of an eight-week loading phase, this trial tested acute dosing strategies right around the exercise window.
Researchers tested two very specific dosing regimens during this younger-runner trial. The first regimen required participants to take a single 12-gram dose exactly 30 minutes before exercise. The second regimen utilized a split-dose strategy to distribute the intake across the training session. For the split protocol, runners took 6 grams before exercise and another 6 grams precisely at the 12-kilometer mark.
For the ambitious endurance athlete over 35, recovery is often the ultimate limiting factor for long-term progression. Aging naturally increases the time required to bounce back from high-volume training blocks. When a supplier reports reductions in cardiac and muscle stress biomarkers, veteran athletes naturally pay close attention. Anything that limits internal muscle damage could theoretically allow for more consistent training weeks.
However, seasoned runners must approach these specific D-ribose claims with strict skepticism. The primary issue is the complete lack of independent peer review for these two trials. The current findings are merely an early research signal rather than established fueling guidance. Important structural results are entirely absent from the available public account.
Older athletes require precise nutrition to repair cellular damage after repeated long runs. Supplements that promise to restore cellular energy are highly appealing because they target the exact mechanisms that slow down as we age. However, relying on partial data to optimize your metabolism is inherently risky. A well-rounded diet already provides the necessary building blocks for natural energy production.
The report does not give absolute completion times or baseline heart-rate values for the runners. It also fails to provide the specific biomarker measurements or any full statistical analyses. We do not even have the completion-time result for women using the split-dose protocol.
Furthermore, the article does not provide trial safety data or an independent safety assessment. The older-runner trial is especially limited in its scope for our broader community. It involved only 40 men, and the public account does not provide subgroup data by age or fitness level. You cannot safely extrapolate these narrow findings to build a universal protocol for all masters athletes.
Evaluating supplements requires looking at effect sizes, confidence intervals, and p-values to understand the true impact. Because this summary omits these details, we cannot tell if the performance gains are statistically meaningful. Endurance nutrition advice must be tested against real-world conditions over extended training blocks. A short trial provides a snapshot, but it does not guarantee long-term performance benefits for older athletes.
You should never replace an established, individually tested race fueling plan with an unpublished supplement finding. The protocols tested in the younger-runner trial involved substantial single-session doses and a mid-run dose. These regimens were controlled trial interventions, not established recommendations for your next starting line. Introducing 12 grams of an unfamiliar supplement right before a long run is a massive gastrointestinal risk.
Testing unknown substances during competition is a common mistake that often leads to severe stomach distress. If you are struggling with recovery, look toward established science rather than supplier-summarized trends. Focus on adequate carbohydrate intake and prioritize proven methods like evaluating your weekly training cycles. You can also compare these new claims against existing supplement research on muscle recovery to maintain proper perspective.
Consistent sleep, proper hydration, and structured progressive overload are still the most reliable tools available. If your baseline recovery feels unusually slow, you should consider when recovery requires professional support rather than reaching for untested supplements. Reendure will continue to monitor these trials, but they do not justify changing your current habits today. Until the underlying data is published and independently verified, D-ribose remains an interesting idea rather than a practical tool.
Until independent peer-reviewed data replaces these supplier summaries, veteran athletes should treat D-ribose as an interesting research signal rather than a reason to rewrite their proven race fueling strategies.
Follow ReEndure for practical insights on endurance training, recovery, nutrition and healthy aging. Stay connected for new articles, research led guidance and ideas to help you perform better for longer.
Read practical ideas on endurance training, recovery, nutrition and healthy aging to keep progressing for years to come.
Read the Blog